Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) dropped 6.7% during mid-day trading on Monday . The stock traded as low as $17.65 and last traded at $17.65. Approximately 100 shares changed hands during trading, a decline of 95% from the average session volume of 1,910 shares. The stock had previously closed at $18.9080.
Shionogi & Co., Ltd. Stock Performance
The firm has a 50-day moving average price of $18.00 and a 200 day moving average price of $19.37.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- The Pentagon’s Grok Rollout Puts These 3 Stocks in Focus
- Copper Surges as Shifting Trade Policy and AI Demand Collide
- Ulta Beauty’s Earnings Beat Was Stronger Than the Stock’s Reaction
- Bancorp’s Fintech Comeback Gains Momentum
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
